Log in or Sign up for Free to view tailored content for your specialty!
Hepatitis C News
FDA approves Vosevi for HCV
FDA announced the approval of Vosevi for the treatment of adults with chronic hepatitis C genotypes 1 through 6, according to an agency press release.
New EHR alert increases HCV screening among baby boomers
Implementation of an electronic health record-based prompt significantly increased hepatitis C screening rates among baby boomers in primary care.
Log in or Sign up for Free to view tailored content for your specialty!
Age, diabetes, BMI affect early hospitalization rates post-LT
Risk factors associated with hospitalization within 6 months following liver transplantation included age, hepatitis C, diabetes, high BMI and poor renal function, while race and liver donation after cardiac death affected mortality risk, according to recently published data. Each hospitalization within the first 6 months after liver transplantation increased mortality risk by 22%.
Triple therapy DAA leads to SVR after virologic relapse
The direct-acting antiviral combination of grazoprevir, ruzasvir and uprifosbuvir, with or without ribavirin, for either 16 or 24 weeks was safe and effective for patients with hepatitis C who had previously failed NS5A inhibitor-containing treatment, according to results of two phase 2 studies.
DAAs do not affect HCC risk, SVR reduces risk
Recently published data showed a link between sustained virologic response and a reduced risk for hepatocellular carcinoma among patients treated with direct-acting antivirals for hepatitis C.
Standard HBV vaccination safe for patients with HCV infection
The standard schedule of hepatitis B vaccination was safe and showed good immunogenicity among patients who were already infected with hepatitis C virus, according to recently published findings from China.
HBV, HCV diagnoses show improved timing in late-stage liver disease
Late diagnosis of hepatitis B and hepatitis C has declined over time among patients with decompensated cirrhosis and those with hepatocellular carcinoma, according to a recently published study. Further, patients with more regular physician visits and lower risk activities were diagnosed earlier.
Top HCV reports for June 2017 focus on guides, screening
In the direct-acting antiviral era, researchers and medical professionals are continuing their efforts to eliminate hepatitis C by defining the most instrumental guides for screening, treatment and management.
French patients with HIV/HCV achieve high SVR rate
Researchers observed a significantly high sustained virologic response among patients coinfected with HIV and hepatitis C who were enrolled in the French nationwide ANRS CO13 HEPAVIH observational cohort study, according to a recently published report.
Trump nominates needle exchange advocate for US Surgeon General
President Donald J. Trump has nominated Jerome M. Adams, MD, MPH, who has advocated for needle exchange programs, to be the next U.S. Surgeon General.